Paul Tu
Venture Partner @ Oxford Bioscience Partners
Paul Tu is a Series B investor at Oxford Bioscience Partners focused on Database and Security. Paul Tu has over 20 years of operational, entrepreneurial and investment experience. Paul is currently Managing Partner of Blue Ocean Equity Partners and leads the firm's acquisition activities. He is also a Venture Partner of Oxford Bioscience Partners. Most recently, Paul co-founded BGI Americas Corporation and brought BGI, a Chinesegenomics sequencing service provider, into the US market. As President of BGI Americas, Paul built a full staff and achieved positive returns within the first year of operations, and collaborated with leading pharmaceutical companies, including Merck, Pfizer, Novartis and Eli Lilly, etc..Prior to BGI Americas, Paul was a Principal at MassVentures, a Boston-based venture capital firm. Over his 10 years at MassVentures, Paul was involved in all aspects of investing and managing investments in privately held companies, including serving on their boards of directors and working closely with their executives to develop strategies, recruit senior management and secure follow-on financing. Paul's previous investments included uTest, the world's largest marketplace for software testing services and winner of the "Most Innovative Company of the Year" by American Business Awards in 2011; Inceptor Inc., a search engine marketing software company acquired by SuperMedia (NASDAQ: SPMD); and Profile Systems, a supply chain management software and service provider acquired by Comergent Technologies Inc. and subsequently acquired by Sterling Commerce, a subsidiary of AT&T Inc. (NYSE: T). Before MassVentures, Paul was Vice President at Eastern Bank Commercial Lending Group and Assistant Vice President at Bank of America (formerly Fleet Bank/Shawmut Bank) Business Banking Group. Paul holds an MBA from MIT Sloan School of Management and a B.S. from Boston University.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries Paul Tu invests in
Stages Paul Tu invests in
Countries Paul Tu invests in
Investment Focus
Industry
- Database 1 (100%)
- Security 1 (100%)
- Software 1 (100%)
- IT Management 1 (100%)
- Private Cloud 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
Managing security and compliance is a strategic, economic imperative that directly impacts business outcomes. Ntirety is the only company that embeds compliant security throughout your IT and company culture. Protect the entirety of your enterprise through a comprehensive compliant security solution from a single relationship. With over 20 years ofexperience and deep security expertise, our three 24x7x365 US-based security operations centers (SOCs) simplify your risk management program with a comprehensive protection, recovery and assurance suite of services. Our approach helps you build resilient, adaptive operations throughout all your organization. Discover the award-winning Ntirety Compliant Security Solution that’s tested, proven, and trusted globally. Learn more at ntirety.com. | Series B / Mar 26, 2008 |
About Oxford Bioscience Partners
Oxford Bioscience Partners (OBP), established in 1992, is a venture capital firm that provides equity financing and management assistance to emerging, entrepreneurial-driven companies within the life sciences and healthcare sectors. While willing to consider an investment in a company at almost any stage, OBP primarily works with early-stagesituations. With approximately $1B of committed capital under management, OBP has invested in over 140 life science companies worldwide.
Oxford Bioscience Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alan G. Walton
Senior General Partner
|
|||
|
Alan Watson
Executive-in-Residence
|
|||
|
Julia Dan
Venture Partner
|
|||
|
Manuel A. Navia
Executive-in-Residence
|
|||
|
Paul Tu
Venture Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Paul Tu invest in?
Paul Tu invests primarily in Database, Security and Software startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Paul Tu last invest?
The most recent investment recorded for Paul Tu closed in Mar 2008. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!